PEAR THERAPEUTICS INC's ticker is and the CUSIP is 704723105. A total of 1 filers reported holding PEAR THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 4,502 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | -100.0% | 4,502 | 0.0% | 0.00% | – |
| Q1 2023 | $1 | -80.0% | 4,502 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $5 | -99.9% | 4,502 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $9,000 | +28.6% | 4,502 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $7,000 | -69.6% | 4,502 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $23,000 | -17.9% | 4,502 | 0.0% | 0.00% | -20.0% |
| Q4 2021 | $28,000 | – | 4,502 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roble, Belko & Company, Inc | 4,502 | $0 | 0.00% |